ASXL1 mutation in clonal hematopoiesis - ScienceDirect
Dynamic ASXL1 Exon Skipping and Alternative Circular Splicing in Single Human Cells | PLOS ONE
Schematic representation of the ASXL1 mutation in exon 12. The various... | Download Scientific Diagram
Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals | Cell Research
Molecular pathways involved in aCML. Mutations in the ASXL1 and EZH2... | Download Scientific Diagram
Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish | Leukemia
ASXL1/2 and multiprotein complex regulation of gene expression by... | Download Scientific Diagram
ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine | Blood Cancer Journal
Oncogenic truncations of ASXL1 enhance a motif for BRD4 ET-domain binding | bioRxiv
ASXL1/2 mutations and myeloid malignancies | Journal of Hematology & Oncology | Full Text
The Role of ASXL1/2 and Their Associated Proteins in Malignant Hematopoiesis | SpringerLink
Hypothetical model for the role of ASXL1 in cell cycle progression... | Download Scientific Diagram
ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts. - Abstract - Europe PMC
The role of ASXL1 in hematopoiesis and myeloid malignancies | SpringerLink
ASXL1 - Wikipedia
ASXL1 mutation in clonal hematopoiesis - ScienceDirect
Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms | SpringerLink
Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation | Haematologica
Altered histone PTM caused by ASXL1-MT and therapeutic strategies. | Download Scientific Diagram
Figure 1 from Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes | Semantic Scholar
ASXL1 (additional sex combs like 1 (Drosophila))
Epigenetics and mutations in chronic myeloproliferative neoplasms | Haematologica
CRISPR/Cas9-mediated ASXL1 mutations in U937 cells disrupt myeloid differentiation